$211.60 0.9%
CRL Stock Price vs. AI Score (Last 150 days)
Data gathered: June 22

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Charles River Laboratories

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.

Charles River Laboratories
Price $211.60
Target Price Sign up
Volume 681,780
Market Cap $10.8B
Year Range $164.52 - $273.43
Dividend Yield 0%
PE Ratio 24.63
Revenue per Employee $203,268
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24998M908M90M73M165M0.000
Q4 '231B261M743M187M277M2.460
Q3 '231.02B225M790M87M180M2.720
Q2 '231.05B234M815M97M196M2.690
Q1 '231.02B875M144M103M200M2.780

Insider Transactions View All

MASSARO GEORGE filed to sell 5,855 shares at $236.8.
May 16 '24
MASSARO GEORGE filed to sell 5,951 shares at $235.6.
May 16 '24
MASSARO GEORGE filed to sell 6,064 shares at $234.7.
May 16 '24
LaPlume Joseph W filed to sell 23,276 shares at $227.
May 14 '24
Knell Michael Gunnar filed to sell 7,024 shares at $267.5.
March 11 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Jun 5, 24 Sell $1K - $15K
Rohit Khanna
Nov 8, 23 Buy $1K - $15K
Lois Frankel
Oct 10, 23 Sell $1K - $15K

What is the Market Cap of Charles River Laboratories?

The Market Cap of Charles River Laboratories is $10.8B.

What is Charles River Laboratories' PE Ratio?

As of today, Charles River Laboratories' PE (Price to Earnings) ratio is 24.63.

How Many People Work at Charles River Laboratories?

As of our latest update, Charles River Laboratories employed approximately 20,000 people worldwide. However, it's important to note that Charles River Laboratories' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Charles River Laboratories' revenue per employee?

$203,268. To calculate Charles River Laboratories' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Charles River Laboratories?

Currently, the price of one share of Charles River Laboratories stock is $211.60.

How can I analyze the CRL stock price chart for investment decisions?

The CRL stock price chart above provides a comprehensive visual representation of Charles River Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Charles River Laboratories shares. Our platform offers an up-to-date CRL stock price chart, along with technical data analysis and alternative data insights.

Does CRL offer dividends to its shareholders?

As of our latest update, Charles River Laboratories (CRL) does not offer dividends to its shareholders. Investors interested in Charles River Laboratories should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Charles River Laboratories?

Some of the similar stocks of Charles River Laboratories are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.